ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 145 filers reported holding ITEOS THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $269,710 | -7.7% | 24,631 | +11.6% | 0.00% | – |
| Q2 2023 | $292,326 | -73.6% | 22,079 | -72.8% | 0.00% | -100.0% |
| Q1 2023 | $1,105,417 | -23.5% | 81,221 | +9.8% | 0.00% | 0.0% |
| Q4 2022 | $1,445,318 | +363.2% | 74,005 | +352.0% | 0.00% | – |
| Q3 2022 | $312,000 | -97.5% | 16,372 | -97.3% | 0.00% | -100.0% |
| Q2 2022 | $12,357,000 | -43.8% | 599,831 | -12.2% | 0.01% | -30.0% |
| Q1 2022 | $21,973,000 | +3748.2% | 682,802 | +5465.3% | 0.01% | – |
| Q4 2021 | $571,000 | -69.9% | 12,269 | -82.5% | 0.00% | -100.0% |
| Q3 2021 | $1,895,000 | +4.6% | 70,167 | -0.6% | 0.00% | 0.0% |
| Q2 2021 | $1,811,000 | -26.0% | 70,584 | -1.5% | 0.00% | 0.0% |
| Q1 2021 | $2,448,000 | +806.7% | 71,627 | +798.3% | 0.00% | – |
| Q4 2020 | $270,000 | +91.5% | 7,974 | +39.7% | 0.00% | – |
| Q3 2020 | $141,000 | – | 5,707 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MPM ASSET MANAGEMENT LLC | 3,706,663 | $126,694,000 | 24.48% |
| MPM BioImpact LLC | 2,355,557 | $80,513,000 | 10.12% |
| Boxer Capital, LLC | 4,345,016 | $148,513,000 | 5.04% |
| RA Capital Management | 4,417,258 | $150,982,000 | 2.28% |
| Ally Bridge Group (NY) LLC | 322,794 | $11,033,000 | 2.12% |
| Asymmetry Capital Management, L.P. | 102,286 | $3,496,000 | 1.81% |
| RTW INVESTMENTS, LP | 2,762,791 | $94,432,000 | 1.47% |
| COWEN AND COMPANY, LLC | 588,238 | $20,106,000 | 1.38% |
| Artal Group S.A. | 1,094,047 | $37,395,000 | 0.66% |
| HighVista Strategies LLC | 19,804 | $677,000 | 0.50% |